This site is intended for healthcare professionals
Drug news

Roche acquires non US rights to SRP 9001 from Sarepta Therapeutics, a treatment for Duchenne muscular dystrophy.

Read time: 1 mins
Last updated:24th Dec 2019
Published:24th Dec 2019
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest